Yoshiteru Nakano

Dr. Yoshiteru Nakano

orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2019 in World Neurosurgery
Verified
Journal Article
Closed access
YNYoshiteru Nakano
Yoshiteru Nakano
TKTakehiro Kitagawa
Takehiro Kitagawa
YOYoshio Osada
Yoshio Osada
TTTohru Tanaka
Tohru Tanaka
SNShigeru Nishizawa
Shigeru Nishizawa
JYJunkoh Yamamoto
Junkoh Yamamoto

1 October 2015 in Journal Of Neuroradiology
Verified
Journal Article
Closed access
YNYoshiteru Nakano
Yoshiteru Nakano
JYJunkoh Yamamoto
Junkoh Yamamoto
MTMayu Takahashi
Mayu Takahashi
YSYoshiteru Soejima
Yoshiteru Soejima
DADaisuke Akiba
Daisuke Akiba
SNShigeru Nishizawa
Shigeru Nishizawa

1 June 2019 in World Neurosurgery
Verified
Journal Article
Closed access
KTKeita Toh
Keita Toh
KSKohei Suzuki
Kohei Suzuki
RMRyo Miyaoka
Ryo Miyaoka
TKTakehiro Kitagawa
Takehiro Kitagawa
TSTakeshi Saito
Takeshi Saito
JYJunkoh Yamamoto
Junkoh Yamamoto

1 January 2021 in Neurologia medico-chirurgica
Verified
Journal Article
Open access
PDF file
RMRyo Miyaoka
Ryo Miyaoka
JYJunkoh Yamamoto
Junkoh Yamamoto
HMHiroshi Miyachi
Hiroshi Miyachi
KSKohei Suzuki
Kohei Suzuki
TSTakeshi Saito
Takeshi Saito
YNYoshiteru Nakano
Yoshiteru Nakano
The endovascular perforation (EP) model is a common technique for experimental subarachnoid hemorrhage (SAH) in rats, simulating the pathophysiological features observed in the acute phase of SAH. Due to the drawbacks of large variations in the amount of bleeding, the results obtained from this model require severity evaluation. However, no less-invasive procedure could confirm the precise intracranial conditions immediately after establishing the rat EP model. We created a novel method for evaluating SAH immediately after establishing the rat EP model using intra-arterial contrast-enhanced micro-computed tomography (CT). We administered contrast agents continuously via the carotid artery during surgery and performed CT examination immediately after SAH induction. First, bleeding severity was classified by establishing a scoring system based on the CT findings (cSAH scoring system). Subsequently, we determined the actual SAH distribution macroscopically and histologically and compared it with the cSAH scores. Second, we investigated the contrast agent’s neurotoxicity in rats. Finally, we confirmed the correlation between cSAH scores and SAH severity, including neurological status, cerebral vasospasm, and hematoma volume 24 hr after SAH. Intra-arterial contrast-enhanced micro-CT could visualize the distribution of SAH proportionally to the bleeding severity immediately after establishing the EP model. Moreover, the contrast agent administration was determined not to be neurotoxic to rats. The cSAH scoring revealed a significant correlation with the SAH severity in the rat EP model (P <0.01). Thus, our minimally invasive method provided precise information on intracranial status in the ultra-early phase of SAH in rats EP model.

6 October 2021 in Surgical Neurology International
Verified
Journal Article
Open access
TSTaichi Shimabukuro
Taichi Shimabukuro
KSKohei Suzuki
Kohei Suzuki
YNYoshiteru Nakano
Yoshiteru Nakano
JYJunkoh Yamamoto
Junkoh Yamamoto
Background: Ewing’s sarcoma (ES) is a malignancy that arises from bones or soft tissue, characterized by primitive small and round blue cells. Primary ES typically occurs in the long bones, vertebrae, or pelvis, and is extremely rare in the skull base. Case Description: A 14-year-old girl presented with posterior cervical pain and dysfunction of multiple cranial nerves (CNs). Radiological investigation revealed a solid mass of the petroclival bone extending into the sphenoid sinus. The patient underwent endoscopic transsphenoidal surgery for diagnosis of the pathology, and partial resection was safely achieved. Histopathological, genetic, and radiological examinations confirmed the diagnosis of primary ES. Subsequently, the patient underwent adjuvant chemotherapy and radiotherapy following which the clinical symptoms resolved. Complete response was achieved after multimodal treatment. Twenty months after treatment, the patient remains in remission without recurrence or metastatic disease. Primary ES of the petroclival bone has been reported in only three cases in the literature. As seen in the present case, dysfunction of multiple CNs is the most common manifestation of petroclival ES. Diagnosis should be confirmed by histopathological and genetic examinations considering the nonspecific clinical symptoms and radiological features. Conclusion: Multimodal treatment, including surgery, chemotherapy, and radiotherapy, can result in favorable outcomes. Clinicians should consider safe resection during surgical management to prevent complications that can delay postoperative multimodal treatment.

1 December 2018 in World Neurosurgery
Verified
Journal Article
Closed access
JYJunkoh Yamamoto
Junkoh Yamamoto
SKShingo Kakeda
Shingo Kakeda
SSShohei Shimajiri
Shohei Shimajiri
YNYoshiteru Nakano
Yoshiteru Nakano
TSTakeshi Saito
Takeshi Saito
SNShigeru Nishizawa
Shigeru Nishizawa